Marina Biotech has acquired the intellectual property for the Smarticles liposomal-based delivery system from Novosom AG.
ATMI completes expansion at US bioprocess tech plant days after citing life science business growth as an important part of its second quarter gains.
The medical unit of Becton Dickinson (BD) reported a slight increase in revenues in the third quarter driven by solid sales of diabetes products.
Mylan hopes new solid-dose packaging plant in Hungary will help it increase market share in Eastern Europe.
Demand for drug discovery services is growing again according to Domainex, who predicted that we will see greater pharmaceutical industry reliance on specialist CROs going forward.
GSK has awarded the National Comprehensive Cancer Network (NCCN) grants worth $4m to support trials involving ofatumumab and pazopanib.
CRO Chiltern International says market share grew in fiscal 2010, citing strengthened industrial relationships and global expansion as drivers.
Covance has recorded a 29 per cent drop in operating income, despite revenue growth, as cost reduction actions and Phase III delays hit margins.
|
|
Globalisation
More news |
|
|
Lifecycle management
More news |
|
|
Counterfeiting
More news |
|
|
Mergers and acquisitions
More news |
Covering PPD and Pfizer, Sweden and Switzerland our European map-based quiz tests your knowledge of recent biopharm events against colleagues, peers and our community of readers...